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Abstract
Objective Accurate and precise measurement of vestibular schwannoma (VS) size is key to clinical management decisions. 
Linear measurements are used in routine clinical practice but are prone to measurement error. This study aims to compare a 
semi-automated volume segmentation tool against standard linear method for measuring small VS. This study also examines 
whether oblique tumour orientation can contribute to linear measurement error.
Study design Experimental comparison of observer agreement using two measurement techniques.
Setting Tertiary skull base unit.
Participants Twenty-four patients with unilateral sporadic small (< 15 mm maximum intracranial dimension) VS imaged 
with 1 mm-thickness T1-weighted Gadolinium enhanced MRI.
Main outcome measures (1) Intra and inter-observer intraclass correlation coefficients (ICC), repeatability coefficients (RC), 
and relative smallest detectable difference (%SDD). (2) Mean change in maximum linear dimension following reformatting 
to correct for oblique orientation of VS.
Results Intra-observer ICC was higher for semi-automated volumetric when compared with linear measurements, 0.998 
(95% CI 0.994–0.999) vs 0.936 (95% CI 0.856–0.972), p < 0.0001. Inter-observer ICC was also higher for volumetric vs 
linear measurements, 0.989 (95% CI 0.975–0.995) vs 0.946 (95% CI 0.880–0.976), p = 0.0045. The intra-observer %SDD 
was similar for volumetric and linear measurements, 9.9% vs 11.8%. However, the inter-observer %SDD was greater for 
volumetric than linear measurements, 20.1% vs 10.6%. Following oblique reformatting to correct tumour angulation, the 
mean increase in size was 1.14 mm (p = 0.04).
Conclusion Semi-automated volumetric measurements are more repeatable than linear measurements when measuring small 
VS and should be considered for use in clinical practice. Oblique orientation of VS may contribute to linear measurement 
error.
Keywords Vestibular schwannoma · Acoustic neuroma · Measurement · Volumetric · Semi-automated
Introduction
When small or intracannalicular vestibular schwannomas 
(VS) are observed, around two-thirds may remain stable on 
serial imaging [1, 2]. For patients with growing tumours, 
active treatment is offered in the form of radiotherapy or sur-
gery. The ability to accurately determine whether VS have 
grown or are stable is essential for decision-making as well 
as determining efficacy of treatment.
Despite the improved quality and sensitivity of MRI scan-
ning over the last 3 decades, the potential for observer vari-
ation when using linear measurements is well recognized 
[3, 4]. It has been suggested that growth should be defined 
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as an increase in linear dimension of 2 mm or more, since a 
change in size of less than 2 mm could be due to measure-
ment error [3–5]. As a result, volumetric measurements have 
been considered as a potentially more accurate measurement 
of VS size [6–16].
The benefit of volumetric measurements of VS has been 
particularly highlighted within the setting of neurofibroma-
tosis type 2 (NF2) [17–19]. This is largely due to the intro-
duction of novel biological therapies such as bevacizumab 
where reliable monitoring of response is key [6, 19, 20]. In 
addition, patients with NF2 have larger, more irregular, or 
lobular tumours which are more difficult to measure accu-
rately with linear dimensions [8].
The majority of previous studies showing the benefits of 
volumetric over linear measurements of VS have used the 
manual segmentation or Cavilieri method where the tumour 
is manually outlined on each MRI slice and the area mul-
tiplied by slice thickness [10, 14, 16, 21]. This is a time-
consuming technique taking 15–25 min per tumour meas-
urement [10, 14], making it impractical for routine clinical 
practice. Semi-automated volume segmentation tools (auto-
mated tumour outline with manual checking and automated 
propagation through MRI slices) have become available but 
are not widely used in clinical practice.
We hypothesized that volumetric measurement of small 
VS may not provide a significant advantage over conven-
tional linear measurements given that these tumours often 
have a more uniform ellipsoid shape with a greater intracan-
nalicular proportion than larger tumours [13]. The previ-
ous volumetric vs linear comparison studies have included 
patients with all tumour sizes and patients with NF2 [6, 8, 
18, 22, 23] or excluded patients with purely intracanalicular 
tumours [3]. However, sporadic (non-NF2 related) tumours 
comprise 95% of all newly diagnosed VS and of these, more 
than half are intracanalicular or small (less than 15 mm 
maximum intracranial dimension) and are most likely to be 
managed initially with observation and serial imaging [24].
This study aimed to determine if semi-automated volume 
segmentation was more precise than the conventional linear 
methods for measuring sporadic small and intracanalicular 
VS. A further aim was to determine if oblique orientation of 
the long axis of the tumour could contribute to linear meas-
urement error, and if so, whether this could be addressed 
by oblique reformatting to improve linear measurement 
accuracy.
Methods
A departmental database was screened to identify all 
patients with a unilateral intracanalicular or small sporadic 
VS imaged with T1-weighted gadolinium contrast-enhanced 
MRI acquired with 1 mm slice thickness within the last 
3 years. These imaging requirements were selected as opti-
mal for volumetric analysis and oblique reformatting but 
were only available in patients who had undergone 3D image 
acquisition with isotropic voxels for stereotactic radiother-
apy planning. Patients with NF2, aged under 18 or tumours 
larger than 15 mm maximum intracranial dimension were 
excluded. Tumours with maximum intracranial dimension 
less than 15 mm are defined as ‘small’ in line with the Brit-
ish National Vestibular Schwannoma Audit, however, for the 
purpose of this study, tumour measurements also included 
the intrameatal (intratemporal component) and are presented 
as maximum axial dimension.
Two observers (one neuroradiologist and one neurotolo-
gist) independently measured each tumour using both linear 
and semi-automated volumetric techniques. Both observers 
were blinded to any previous measured values and repeated 
measurements were made to provide intra and inter-observer 
repeatability comparisons.
Linear measurements were made in the axial plane using 
a digital caliper on a GE Advantage Workstation version 
4.5 (GE Healthcare, Waukesha, USA), taking the maximum 
axial dimension including the intracanalicular component. 
Volumetric measurements were made using Olea  Sphere® 
Version 2.3 (Olea  Medical®, La Ciotat, France), a post-pro-
cessing application with volumetric analysis modules, avail-
able commercially for clinical use. The ‘magic wand’ func-
tion was used to select the tumour and to create a region of 
interest (ROI). This uses a ‘region-growing tool’, selecting 
a growing volume whose voxel values are close to the ini-
tially selected voxel, propagated to all other imaging slices 
to cover the entire tumour (Fig. 1).
Oblique reformatting
All tumours were also assessed in the coronal plane and 
the angle of the tumour long axis with respect to the axial 
plane was measured. Where this was greater than an arbi-
trary threshold of 30 degrees, the oblique reformatting tool 
on the GE Advantage Workstation was used to produce axial 
slices transecting the tumour through its long axis (Fig. 2). 
The maximum linear dimension was compared when meas-
ured before and after oblique reformatting.
Statistical analysis
Data analysis was performed using SPSS Version 23 
(SPSS, Chicago, Illinois, USA). Intraclass correlation coef-
ficients (ICC) were calculated for intra and inter-observer 
paired measurements to compare measurement techniques. 
A Fisher r to z calculation was performed to test for sig-
nificant differences between ICC values. Since correlation 
measurement data may be highly correlated whilst having 
poor agreement [25], Bland–Altman plots have been used to 
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Fig. 1  Image of volumetric measurement being made with the Olea Sphere programme. The left VS is highlighted as the ROI (VS vestibular 
schwannoma, ROI region of interest)
Fig. 2  MRI of left VS showing long axis of tumour at 40° angle to the horizontal when viewed in coronal plane (left image), with the obliquely 
reformatted axial image displayed on the right
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graphically demonstrate intra and inter-observer agreement 
for both measurement techniques. Upper and lower limits of 
agreement (LoA) were calculated for each set of measure-
ments and incorporated into the Bland–Altman Plots [26, 
27].
The Repeatability Coefficient (RC) is the difference 
which will be exceeded by only 5% of pairs of measure-
ments on the same tumour [25] (RC = Standard deviation of 
the differences between data pairs × 1.96). To allow for more 
direct comparison between linear and volumetric measure-
ments values, RC was also converted into proportions given 
as the relative smallest detectable difference [%SDD = (RC/
mean tumour size) × 100].
Results
Twenty-four cases were included in the study. The mean 
VS size as determined by maximum axial linear dimension 
was 14.6 mm (SD = 2.5 mm) and mean tumour volume was 
546 mm3 (SD = 383mm3).
Linear vs semi‑automated volumetric 
measurements
Intraclass correlation coefficients (ICC) were excellent for 
all paired measurements (> 0.9). Table 1 shows that the 
ICC were significantly higher for semi-automated volumet-
ric measurements than for linear measurements, especially 
when comparing intra-observer measurements (p < 0.0001). 
Figure 3 plots all four ICC with corresponding 95% confi-
dence intervals (CI) also demonstrating the narrower range 
of 95%CI for semi-automated volumetric measurements. 
Although this figure shows the 95% CI for inter-observer 
linear and semi-automated volumetric ICC are minimally 
overlapping, a Fishers r to z transformation confirms the dif-
ference between the two ICCs is still significant (p = 0.0045).
In addition to a comparison of correlation, levels of 
agreement are displayed in Fig. 4a–d in standard Bland–Alt-
man plots. Equal distribution of points plotted above and 
below the mean of the difference (dashed line) confirms no 
systematic difference between the first and second sets of 
measurements of the same tumour (p > 0.05). Furthermore, 
there does not appear to be a relation between magnitude 
of error and size of tumour. This is confirmed with poor 
correlation coefficients between tumour size and intra/inter-
observer measurement difference (< 0.1 for all four data 
sets).
Repeatability coefficients (RC) were less than 2 mm for 
both intra and inter-observer linear measurements (1.73 and 
1.65 mm). Linear measurement relative smallest detectable 
difference (%SDD) was similar for intra vs inter-observer 
measurements (11.8 and 10.6% respectively). However, 
volumetric intra-observer %SDD was half that of the inter-
observer measurement (9.9 vs 20.1%).
Linear measurement following oblique reformatting
In 5 out of 24 cases, review of images in the coronal plane 
identified the long axis of the tumour to be angulated greater 
than 30° from the axial plane. Following oblique reformat-
ting, all 5 were deemed to be larger on repeat measurement, 
with a mean increase in size of 1.14 mm (range 0.2–2.7 mm; 
p = 0.04).
Table 1  demonstrates the intraclass correlation coefficient (ICC) for each set of paired measurements where 0 is no correlation and 1 is perfect 
correlation
The repeatability coefficient (RC) and relative smallest detectable differences (%SDD) are also displayed
Intra-observer maxi-
mum linear dimension
Inter-observer maxi-
mum linear dimension
Intra-observer semi-
automated volumetric
Inter-observer semi-
automated volu-
metric
Intraclass correlation coefficient (ICC) (95% 
confidence intervals)
0.936 (0.856–0.972) 0.946 (0.880–0.976) 0.998 (0.994–0.999) 0.989 (0.975–0.995)
Repeatability coefficient (RC) 1.73 mm 1.65 mm 54  mm3 110  mm3
Relative smallest detectable difference (%SDD) 11.8% 10.6% 9.9% 20.1%
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Fig. 3  Intra and inter-observer ICC (denoted by filled diamond) for 
linear and semi-automated volumetric measurements with 95% confi-
dence intervals displayed as high-low lines
871European Archives of Oto-Rhino-Laryngology (2018) 275:867–874 
1 3
Discussion
The improvement in the observer agreement using the semi-
automated volumetric technique suggests that this method 
is more precise than the conventional linear method. In the 
absence of comparing both measurement techniques against 
a gold standard, such as comparison to a phantom tumour 
of known size, it is not possible to know how accurate each 
technique is. However, the key information required when 
measuring VS in clinical practice is whether or not there is 
change in size. A measurement technique that demonstrates 
better observer agreement will likely be both sensitive to, 
and more reliable at, correctly detecting growth.
Although this study directly compares correlation coeffi-
cients between linear and semi-automated volumetric meas-
urements, this comparison is potentially flawed, as stated 
previously, as measurement data may be highly correlated 
with poor agreement. Bland–Altman plots have, therefore, 
been constructed and repeatability coefficients (RC) calcu-
lated. The RC is the smallest true change in tumour size that 
can be reliably detected from two separate measurements. 
The previous studies have used the RC to help quantity a 
minimum increase in size that should be regarded as growth 
[3, 4, 8, 10, 13, 14].
Unfortunately, it is not possible to compare the RC of 
linear and volumetric measurement techniques due to dif-
fering units (e.g., 1.73 mm vs 54  mm3). In an attempt to 
reconcile this and allow more direct comparison, the relative 
smallest detectable difference values are presented (%SDD) 
[3, 8, 13].
It is interesting to note that despite the higher inter-
observer ICC of semi-automated volumetric technique, 
Fig. 4  a–d Display standard Bland–Altman plots for all four paired 
measurement sets to show levels of intra and inter-observer agree-
ment for linear and semi-automated volumetric measurement tech-
niques. These plot the difference between the values against the mean 
for each pair of measurements. The dashed line represents the overall 
mean of the differences between sets of measurements. The dotted 
lines are calculated as ± 1.96 × SD and represent the upper and lower 
limits of agreement
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the %SDD is twice that of linear measurements (10.6 vs 
20.1%). This could be misleading in suggesting that the 
volumetric technique has a greater margin of error when 
detecting change in size of VS. However, these conflicting 
results may be explained by geometric differences between 
one- and three-dimensional measurements. For example, if 
an ellipsoid VS of dimensions (20 × 10 × 10 mm) increases 
in size by 10% in all directions, its maximal linear dimen-
sion will have increased from 20 to 22 mm, whereas the 
increase in volume will be from 1047 to 1394  mm3, an 
increase of 32%. Therefore, depending on the geometric 
shape of the tumour and in which dimension it increases, 
the volumetric technique (even with a larger %SDD of 
20%) is likely to be more sensitive at detecting growth 
than the linear method.
The difference between the %SDD for intra vs inter-
observer measurements made with the semi-automated vol-
ume segmentation tool (9.9 vs 20.1%) highlights that the 
semi-automated process is not without risk of human error. 
In this study, variation in the initial selection of the region 
of interest, manual editing out of highlighted peritumoural 
vessels, and the need to manually highlight areas of hypoin-
tensity not included in the automated segmentation were all 
thought to contribute to inter-observer variation.
This study does, however, have limitations that should 
be considered when interpreting the results. The imaging 
protocol used (T1-weighted gadolinium contrast-enhanced 
MRI acquired with 1 mm slice thickness) is not standard 
in many units, and as such, the results may not be general-
izable for use with other imaging protocols, especially in 
units where balanced Steady-State Free Precession (bSSFP) 
sequences are used in place of contrast-enhanced scans. This 
study tests just one commercially available semi-automated 
volume segmentation tool; the results may not necessarily be 
representative of other similar post-processing applications. 
Maximum axial tumour dimension was used as the linear 
measurement method. Although other methods are common, 
there is some evidence that this is the optimal dimension for 
reliability [3].
When considering linear measurement error, there are a 
range of factors that may contribute including differences 
in image acquisition such as slice thickness, change in head 
position, degree of contrast enhancement, and adjustment of 
the tumour image with windowing [28, 29]. To our knowl-
edge, this is the first study to demonstrate that oblique refor-
matting may correct linear measurement error due to oblique 
tumour orientation. The decision to only reformat tumours 
that were obliquely orientated greater than 30° was based 
on a pragmatic approach more reflective of clinical prac-
tice where reformatting would only be undertaken when the 
long axis of the tumour was clearly in an oblique lie to the 
plane of measurement. A limitation of this technique is that 
it requires image slices acquired with volumetric isotropic 
1 mm voxels, which are not necessarily available in routine 
practice.
Comparison with other studies
Many of the previously reported studies use a manual seg-
mentation volume measurement technique which is imprac-
tical for use in daily clinical practice [14, 16, 21, 30]. Some 
studies have used a semi-automated volume segmentation 
tool which uses an ‘active contouring’ algorithm to outline 
the tumour on each slice; each slice area is then automati-
cally summated and multiplied by slice thickness to provide 
a volume [13, 18]. The semi-automated volume segmenta-
tion tool used in the present study (Olea Sphere) utilizes a 
‘region-growing’ algorithm to outline the tumour on a sin-
gle axial slice and automatically propagates the region of 
interest through adjacent slices. The estimated time taken 
to perform a single semi-automated volumetric measure-
ment using Olea Sphere was 60–90 s for both observers. 
This is considerably faster than the previous reports of semi-
automated volume segmentation (3 and 4–7 min) [13, 16] 
and manual segmentation (15–25 min) [10, 14]. As well 
as reducing the time required, the increased automation of 
current tools has the potential to standardize some of the 
measurement process which may also improve repeatability.
In this study, the inter-observer %SDD was 20.1% for 
semi-automated volumetric measurements which is compa-
rable to other similar studies [8, 13–15]. As suggested in the 
previous reports and supported by our results, an increase in 
volume of at least 20% is required to be considered evidence 
of tumour growth.
The linear intra-observer and inter-observer RC were 
better than the previous reports [3, 4, 13]. This may be 
explained by the 1 mm image slice thickness used in this 
study allowing more accurate measurements. In addition, in 
this study, both observers work within the same MDT, and 
this may have resulted in standardization of practice such as 
windowing and boundary edge judgment.
Implications for clinical practice
It is clear from this study, and others than volumetric meas-
urements are more repeatable, precise and will, therefore, 
detect true change in VS size better (and therefore earlier) 
than the conventional linear measurements. Whilst manual 
segmentation was impractical and largely limited to use in 
research, the advent of faster more automated volume analy-
sis tools provides the opportunity for volumetric measure-
ments to be incorporated into routine clinical practice.
Clinical research examining efficacy of treatments for 
VS should regard volumetric measurements as essential, 
given that the increased precision and sensitivity will 
improve the power of any study often reducing the sample 
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size required. However, it remains unclear how the routine 
use of volumetric measurements with improved sensitivity 
would affect patient outcomes.
Our understanding of the natural history of VS is based 
on studies of which almost all used linear measurements 
[1, 2, 5, 31]. It is conceivable that management decisions 
based on evidence of growth from a much more sensi-
tive measurement technique could lead to a larger num-
bers of patients receiving active treatment. However, the 
earlier detection and treatment of VS may not translate 
into improved patient outcomes, since a small change in 
volume is unlikely to result in worse outcomes in terms of 
tumour control after stereotactic radiosurgery [32]. Moreo-
ver, it is recognized that tumours have a variable growth 
behavior and a minority may grow a small amount then 
cease to grow further. This raises the possibility that ear-
lier treatment could result in a minority potentially receiv-
ing treatment unnecessarily. Further research should aim 
to answer these questions.
If semi-automated volume segmentation applications 
are to be used routinely, other factors such as usability and 
cost should be considered and compared between avail-
able tools. For units continuing with linear measurements, 
awareness of oblique orientation and reformatting to cor-
rect this may help to reduce linear measurement error.
Conclusion
This study demonstrates higher repeatability of semi-
automated volume segmentation measurement technique 
over standard linear method for measurement of sporadic 
intracanalicular and small VS. In line with the previous 
research, our results support a linear measurement growth 
criteria of > 2 mm and a volumetric increase > 20%.
If semi-automated volumetric analysis tools are to be 
used more routinely, there is a requirement to compare and 
evaluate the various available post-processing applications 
in an effort to identify the optimal algorithms for use with 
VS. While linear measurement method remains current 
practice in most units, the orientation of VS with respect 
to the horizontal plane should be noted, and if over 30°, 
oblique reformatting should be considered to reduce linear 
measurement error.
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